GGrantIndex
Sort

172,184 grants matching inflammation

Immunoregulatory Defects In Inflammatory Bowel Disease

$959,273
Warren Strober · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI

Differentiation of Clinical Phenotypes of Inflammatory and Neuropathic Ocular Pain Conditions with Morphologic Measures and Functional Brain Imaging

$958,830
Eric Alan Moulton · Boston Children'S Hospital · U01 · FY2024 · EY

Role Of Monocytes In Immunopathology

$958,809
Larry M Wahl · National Institute Of Dental & Craniofacial Research · Z01 · FY2008 · DE

Intracellular Signaling By The Cell Surface Receptor For IgE

$958,808
Juan Rivera · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2012 · AR

Development of a Fully Humanized Antibody for Treating Lung Emphysema

$958,776
Christa Lynn Modery · Allinaire Therapeutics, Llc · R44 · FY2018 · HL

MULTIPURPOSE ARTHRITIS &MUSCULOSKELETAL DISEASES CENTER

$958,687
University Of North Carolina Chapel Hill · P60 · FY2000 · AR

Short-term and long-term effects of methamphetamine exposure on residual viral transcription during treated HIV disease

$958,404
Sulggi Angela Lee · University Of California, San Francisco · R61 · FY2019 · DA

Novel Stem Cell Immunotherapy for MDR-Tuberculosis

$958,345
Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2024 · AI

Design And Development Of Experimental Therapeutics

$958,195
Nigel H. Greig · National Institute On Aging · ZIA · FY2013 · AG

A systems immunology approach to evaluate malaria vaccine performance in endemic regions of Kenya

$958,026
Ann M Moormann · Univ Of Massachusetts Med Sch Worcester · U01 · FY2025 · AI

Role of inflammation, innate resistance, and immunity in carcinogenesis

$957,864
Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Mechanisms of host-commensal interactions with Roseomonas mucosa that modulate innate immune responses to infection with Staphylococcus aureus and support homeostasis of human skin

$957,836
Portia Gough · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

Effects of Time-restricted Eating versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers among Adults with Obesity

$957,734
Lisa Tussing-Humphreys · University Of Illinois At Chicago · R01 · FY2025 · CA

Optical Systems for In Vivo Molecular Imaging of Cancer

$957,734
Rebecca Rae Richards-Kortum · Rice University · R01 · FY2012 · CA

Molecular Mechanisms Of The Autoimmune Lymphoproliferative Syndrome

$957,638
Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI

Improving Outcomes Assessment in Chronic Graft versus Host Disease

$957,625
Stephanie J Lee · Fred Hutchinson Cancer Research Center · R01 · FY2016 · CA

A Randomized Phase 2A Clinical Trial Pioneering the Utility of an eNAMPT-Reducing Therapy in ARDS/VILI: the PUERTA Trial

$957,594
Joe G. N. Garcia · Aqualung Therapeutics Corp. · R44 · FY2024 · HL

Responsive Iron MRI probes with Enhanced Relaxivity

$957,365
Janet R Morrow · Suny At Buffalo · · FY2024 · MPS

A Prospective Study of Diet and Colorectal Neoplasia

$957,301
Charles S Fuchs · Harvard School Of Public Health · U19 · FY2010 · CA

REPRIEVE - DCC

$957,177
Udo Hoffmann · Massachusetts General Hospital · U01 · FY2016 · HL

Integrative And Molecular Studies Of Pain And Pain Control

$957,023
Michael J. Iadarola · National Institute Of Dental & Craniofacial Research · Z01 · FY2008 · DE

KLF control of aging and age-associated cardiovascular disease

$957,000
Mukesh Kumar Jain · Brown University · R35 · FY2023 · HL

Role of Gut and Skin Flora in the Control of Immune Responses

$956,847
Yasmine Belkaid · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI

Reprogramming PDAC Stroma by Targeting Coagulation in the Tumor Microenvironment

$956,721
Bumsoo Han · Purdue University · U01 · FY2022 · CA

Virus Clearance from the Central Nervous System

$956,718
Douglas Craig Hooper · Thomas Jefferson University · R01 · FY2011 · AI